Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be Increased To $0.305
Recent Dividend Declarations
Utah Medical Products To Go Ex-Dividend On December 16th, 2024 With 0.305 USD Dividend Per Share
December 11th (Eastern Time) - $Utah Medical Products(UTMD.US)$ is trading ex-dividend on December 16th, 2024.Shareholders of record on December 16th, 2024 will receive 0.305 USD dividend per share
The Past Three Years for Utah Medical Products (NASDAQ:UTMD) Investors Has Not Been Profitable
Buffett's make-up company Ultra, in which he holds shares, unexpectedly saw an increase in store sales, prompting an upward adjustment of the lower end of the full-year sales guidance range.
The December 6th report from Gelonhui | Utah Beauty's third quarter EPS was $5.14, exceeding analyst expectations of $4.53. Same-store sales growth in the third quarter was 0.6%, lower than the analyst's expected decline of 1.87%. Third-quarter net sales reached $2.53 billion, exceeding the analyst's expectation of $2.5 billion. Expected full-year EPS is $23.2-$23.75, originally forecast by the company at $22.60-$23.50. Expected full-year net sales of $11.1 billion-$-11.2 billion, originally forecast by the company at $11 billion-$11.2 billion. Anticipated same-store sales for the full year to decrease by 1% to grow by 0%, lower than the analyst's expected decline of 0.78.
Utah Medical Products' (NASDAQ:UTMD) Soft Earnings Don't Show The Whole Picture
Utah Medical Products | 10-Q: Q3 2024 Earnings Report
With 66% Institutional Ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) Is a Favorite Amongst the Big Guns
Utah Medical Products GAAP EPS of $3.09, Revenue of $31.74M
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
Utah Beauty's same-store sales fell by 1.2% in the second quarter, falling short of analyst expectations.
On August 30th, Utah Beauty's same-store sales fell by 1.2%, while analysts expected growth of 1.32%. Net sales for the second quarter were $2.6 billion, with analysts expecting $2.61 billion. Net sales for the full year are expected to be $11 billion to $11.2 billion, compared to the company's original forecast of $11.5 billion to $11.6 billion. Same-store sales for the full year are expected to decline by 2% to zero growth, compared to the company's original expectation of 2%-3%, while analysts expect growth of 1.89%.
Will Weakness in Utah Medical Products, Inc.'s (NASDAQ:UTMD) Stock Prove Temporary Given Strong Fundamentals?
Utah Medical Products | 10-Q: Q2 2024 Earnings Report
Utah Medical Products To Go Ex-Dividend On September 20th, 2024 With 0.3 USD Dividend Per Share
August 2nd (Eastern Time) - $Utah Medical Products(UTMD.US)$ is trading ex-dividend on September 20th, 2024.Shareholders of record on September 20th, 2024 will receive 0.3 USD dividend per share on
Utah Medical Products Second Quarter 2024 Earnings: EPS: US$0.98 (Vs US$1.16 in 2Q 2023)
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Reports Q2 Revenue $10.4M
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
Capital Allocation Trends At Utah Medical Products (NASDAQ:UTMD) Aren't Ideal
Investors in Utah Medical Products (NASDAQ:UTMD) Have Unfortunately Lost 27% Over the Last Year
With 65% Ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) Boasts of Strong Institutional Backing
Unlock the Full List